TIL therapy involves isolating TIL cells from tissue near the tumor, amplifying them in vitro with growth factor IL-2, and then reinfusing them into the patient’s body to expand the immune response and treat primary or metastatic tumors (Fig. 5b).179 TIL therapy focuses on identifying T cells that effectively target cancer’s specific mutations. This evidence concerns the gene IL2 and cancer.